Characterization of plasmids encoding extended-spectrum -lactamases and their addiction systems circulating among Escherichia coli clinical isolates in the UK
Authors:
Open Access
- 29 December 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 67 (4) , 878-885
Abstract
To characterize plasmids encoding extended-spectrum β-lactamases (ESBLs) from a recent UK collection of clinical Escherichia coli isolates. The isolates comprised 118 ESBL producers referred from 54 laboratories. Plasmids were transferred by electroporation, and their incompatibility groups, associated addiction systems and resistance genes with the flanking genetic environments were identified by PCR or sequencing. Seventy isolates had plasmids encoding CTX-M-15 (n = 53), CTX-M-14 (n = 9), CTX-M-27 (n = 1), CTX-M-3 (n = 2) and SHV-12 (n = 5) ESBLs that were transformable; non-transformable ESBLs were mainly CTX-M enzymes (42/48). Most transformable blaCTX-M-15 genes (43/53) were harboured on single replicon or multireplicon IncF plasmids, with IncFIA4-FIB1-FII31 (n = 11) and IncFIA1-FII2 (n = 15) being most frequent; the latter included eight pEK499 plasmids, typical of UK epidemic strain A. Plasmids harbouring blaCTX-M-14 belonged variously to IncF, IncI1 and IncHI2 types, and 16 encoding CTX-M or SHV enzymes were non-typeable. Only IncF plasmid types carried the addiction systems sought and those with blaCTX-M-15 frequently harboured blaOXA-1 and aac(6′)-Ib-cr, and often transferred trimethoprim and tetracycline resistance; those with blaCTX-M-14 encoded trimethoprim, sulphonamide, streptomycin and tetracycline resistance. Most ESBL genes were associated with the well-known mobile elements ISEcp1 and IS26, but nearly half (23/55) of the ISEcp1 sequences upstream of blaCTX-M-15 were interrupted by an IS26 at various positions. Most ESBLs (70/118) were encoded by transformable plasmids, although a sizable minority could not be transformed. The majority of transformable plasmids (51/70; 72.9%) were diverse multiresistant IncF types possessing multiple addiction systems. The spread of blaCTX-M-15 can be attributed not just to clonal expansion, but also to the horizontal dissemination of related plasmids.Keywords
This publication has 32 references indexed in Scilit:
- Complete Nucleotide Sequence of Plasmid pTN48, Encoding the CTX-M-14 Extended-Spectrum β-Lactamase from anEscherichia coliO102-ST405 StrainAntimicrobial Agents and Chemotherapy, 2011
- Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strainJournal of Antimicrobial Chemotherapy, 2010
- Molecular characterization of addiction systems of plasmids encoding extended-spectrum β-lactamases in Escherichia coliJournal of Antimicrobial Chemotherapy, 2010
- High Prevalence of ST131 Isolates Producing CTX-M-15 and CTX-M-14 among Extended-Spectrum-β-Lactamase-Producing Escherichia coli Isolates from CanadaAntimicrobial Agents and Chemotherapy, 2010
- Complete Nucleotide Sequences of Plasmids pEK204, pEK499, and pEK516, Encoding CTX-M Enzymes in Three Major Escherichia coli Lineages from the United Kingdom, All Belonging to the International O25:H4-ST131 CloneAntimicrobial Agents and Chemotherapy, 2009
- Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strainsJournal of Antimicrobial Chemotherapy, 2009
- New Plasmid-Mediated Quinolone Resistance Gene, qnrC , Found in a Clinical Isolate of Proteus mirabilisAntimicrobial Agents and Chemotherapy, 2009
- High Prevalence of Plasmid-Mediated Quinolone Resistance Genes qnr and aac(6′)-Ib-cr in Clinical Isolates of Enterobacteriaceae from Nine Teaching Hospitals in ChinaAntimicrobial Agents and Chemotherapy, 2008
- Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concernThe Lancet Infectious Diseases, 2008
- Rapid Dissemination and Diversity of CTX-M Extended-Spectrum β-Lactamase Genes in Commensal Escherichia coli Isolates from Healthy Children from Low-Resource Settings in Latin AmericaAntimicrobial Agents and Chemotherapy, 2007